Skip to main content
Caplight Logo









BacterioScan, Inc.

BacterioScan, Inc.

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.bacterioscan.com/

Last Round

Bankruptcy

Nov 15, 2021

Total Funding Raised

$8.61M

Company Overview

BacterioScan, Inc. is a medical device company that develops rapid diagnostic technology for the detection and quantification of bacteria in fluid samples.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

in-vitro diagnosticsIVDurinary tract infection detectionUTI testingrapid diagnostic systemlaser light-scatteringantibiotic stewardshipclinical microbiologybacterial quantificationmedical device manufacturerpoint of care diagnosticslab automationdiagnostic consumablesbacterial culture alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BacterioScan, Inc. Comparables

Compare BacterioScan, Inc. with similar companies based on industry and business-model similarity.

BacterioScan, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sansure Biotech Inc.
79%
FluoretiQ
78%
Astek Diagnostics
77%

BacterioScan, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
BankruptcyNov 15, 2021
DebtApr 29, 2020
VC RoundAug 7, 2015
Series ADec 11, 2014
SeedMay 20, 2013

Key People

Founding team and executive leadership

Dan Regelman

Founder, Technology Inventor and former CTO

Founding Team

Mike Thaman

Chairman and CEO

Executive Team

Juan Lopez

COO

Executive Team

BacterioScan, Inc. Investors

Notable investors and investment history

BacterioScan, Inc. investors
InvestorRounds
Missouri Technology CorporationSeries A
St. Louis Arch AngelsSeed, VC Round
BioGenerator VenturesSeries A
Warson Capital PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 1286% MoM.

  • Jan 2, 2026

    Monthly visitors increased 68% MoM.

BacterioScan, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BacterioScan, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BacterioScan, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range16
Year Founded2005
Last FundingNov 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?